These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10224229)

  • 1. Melatonin blocks the activation of estrogen receptor for DNA binding.
    Rato AG; Pedrero JG; Martinez MA; del Rio B; Lazo PS; Ramos S
    FASEB J; 1999 May; 13(8):857-68. PubMed ID: 10224229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.
    Ram PT; Kiefer T; Silverman M; Song Y; Brown GM; Hill SM
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):53-64. PubMed ID: 9723886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
    Oesterreich S; Zhang Q; Hopp T; Fuqua SA; Michaelis M; Zhao HH; Davie JR; Osborne CK; Lee AV
    Mol Endocrinol; 2000 Mar; 14(3):369-81. PubMed ID: 10707955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.
    Hill SM; Spriggs LL; Simon MA; Muraoka H; Blask DE
    Cancer Lett; 1992 Jul; 64(3):249-56. PubMed ID: 1638517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness.
    Fernandez P; Burghardt R; Smith R; Nodland K; Safe S
    Eur J Pharmacol; 1994 Jan; 270(1):53-65. PubMed ID: 8157081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC; Krieg S; Shapiro DJ
    Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R; Porter W; Safe S
    Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes.
    Steinhilber D; Brungs M; Werz O; Wiesenberg I; Danielsson C; Kahlen JP; Nayeri S; Schräder M; Carlberg C
    J Biol Chem; 1995 Mar; 270(13):7037-40. PubMed ID: 7706239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
    Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.
    Klinge CM; Kaur K; Swanson HI
    Arch Biochem Biophys; 2000 Jan; 373(1):163-74. PubMed ID: 10620335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
    Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM
    Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
    Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
    Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin.
    Ram PT; Yuan L; Dai J; Kiefer T; Klotz DM; Spriggs LL; Hill SM
    J Pineal Res; 2000 May; 28(4):210-8. PubMed ID: 10831156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines.
    Kanishi Y; Kobayashi Y; Noda S; Ishizuka B; Saito K
    J Pineal Res; 2000 May; 28(4):227-33. PubMed ID: 10831158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
    Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide antagonists of the human estrogen receptor.
    Norris JD; Paige LA; Christensen DJ; Chang CY; Huacani MR; Fan D; Hamilton PT; Fowlkes DM; McDonnell DP
    Science; 1999 Jul; 285(5428):744-6. PubMed ID: 10426998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.